First Trust Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $110M | Buy |
|
|||||
2025
Q1 | $90.5M | Buy |
|
|||||
2024
Q4 | $78.2M | Buy |
|
|||||
2024
Q3 | $69.5M | Sell |
|
|||||
2024
Q2 | $90.4M | Buy |
|
|||||
2024
Q1 | $72.1M | Sell |
|
|||||
2023
Q4 | $253M | Buy |
|
|||||
2023
Q3 | $104M | Sell |
|
|||||
2023
Q2 | $117M | Buy |
|
|||||
2023
Q1 | $107M | Buy |
|
|||||
2022
Q4 | $76.2M | Sell |
|
|||||
2022
Q3 | $104M | Sell |
|
|||||
2022
Q2 | $89.6M | Buy |
|
|||||
2022
Q1 | $83.7M | Buy |
|
|||||
2021
Q4 | $82.9M | Buy |
|
|||||
2021
Q3 | $93M | Sell |
|
|||||
2021
Q2 | $150M | Buy |
|
|||||
2021
Q1 | $118M | Buy |
|
|||||
2020
Q4 | $101M | Sell |
|
|||||
2020
Q3 | $123M | Buy |
|
|||||
2020
Q2 | $106M | Sell |
|
|||||
2020
Q1 | $152M | Sell |
|
|||||
2019
Q4 | $161M | Buy |
|
|||||
2019
Q3 | $98.7M | Sell |
|
|||||
2019
Q2 | $135M | Buy |
|
|||||
2019
Q1 | $96.1M | Buy |
|
|||||
2018
Q4 | $115M | Buy |
|
|||||
2018
Q3 | $121M | Buy |
|
|||||
2018
Q2 | $74.3M | Buy |
|
|||||
2018
Q1 | $64.4M | Buy |
|
|||||
2017
Q4 | $66.7M | Sell |
|
|||||
2017
Q3 | $69.6M | Buy |
|
|||||
2017
Q2 | $39.9M | Sell |
|
|||||
2017
Q1 | $43.8M | Sell |
|
|||||
2016
Q4 | $56.5M | Buy |
|
|||||
2016
Q3 | $39.5M | Sell |
|
|||||
2016
Q2 | $32.4M | Sell |
|
|||||
2016
Q1 | $35.7M | Sell |
|
|||||
2015
Q4 | $125M | Sell |
|
|||||
2015
Q3 | $134M | Sell |
|
|||||
2015
Q2 | $205M | Buy |
|
|||||
2015
Q1 | $144M | Sell |
|
|||||
2014
Q4 | $130M | Buy |
|
|||||
2014
Q3 | $120M | Buy |
|
|||||
2014
Q2 | $111M | Buy |
|
|||||
2014
Q1 | $107M | Buy |
|
|||||
2013
Q4 | $74.9M | Sell |
|
|||||
2013
Q3 | $70.2M | Buy |
|
|||||
2013
Q2 | $51.9M | Buy |
|